Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Intangibles: 2015-2024

Historic Intangibles for Fortress Biotech (FBIO) over the last 10 years, with Dec 2024 value amounting to $31.9 million.

  • Fortress Biotech's Intangibles rose 60.67% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 60.67%. This contributed to the annual value of $31.9 million for FY2024, which is 57.06% up from last year.
  • Fortress Biotech's Intangibles amounted to $31.9 million in FY2024, which was up 57.06% from $20.3 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Intangibles registered a high of $31.9 million during FY2024, and its lowest value of $12.6 million during FY2021.
  • Its 3-year average for Intangibles is $26.4 million, with a median of $27.2 million in 2022.
  • As far as peak fluctuations go, Fortress Biotech's Intangibles slumped by 32.54% in 2021, and later soared by 116.67% in 2022.
  • Fortress Biotech's Intangibles (Yearly) stood at $18.6 million in 2020, then tumbled by 32.54% to $12.6 million in 2021, then surged by 116.67% to $27.2 million in 2022, then fell by 25.41% to $20.3 million in 2023, then soared by 57.06% to $31.9 million in 2024.